Benefits of massage-myofascial release therapy on pain, anxiety, quality of sleep, depression, and quality of life in patients with fibromyalgia

Adelaida María Castro-Sánchez, Guillermo A Matarán-Peñarrocha, José Granero-Molina, Gabriel Aguilera-Manrique, José Manuel Quesada-Rubio, Carmen Moreno-Lorenzo, Adelaida María Castro-Sánchez, Guillermo A Matarán-Peñarrocha, José Granero-Molina, Gabriel Aguilera-Manrique, José Manuel Quesada-Rubio, Carmen Moreno-Lorenzo

Abstract

Fibromyalgia is a chronic syndrome characterized by generalized pain, joint rigidity, intense fatigue, sleep alterations, headache, spastic colon, craniomandibular dysfunction, anxiety, and depression. The purpose of the present study was to determine whether massage-myofascial release therapy can improve pain, anxiety, quality of sleep, depression, and quality of life in patients with fibromyalgia. A randomized controlled clinical trial was performed. Seventy-four fibromyalgia patients were randomly assigned to experimental (massage-myofascial release therapy) and placebo (sham treatment with disconnected magnotherapy device) groups. The intervention period was 20 weeks. Pain, anxiety, quality of sleep, depression, and quality of life were determined at baseline, after the last treatment session, and at 1 month and 6 months. Immediately after treatment and at 1 month, anxiety levels, quality of sleep, pain, and quality of life were improved in the experimental group over the placebo group. However, at 6 months postintervention, there were only significant differences in the quality of sleep index. Myofascial release techniques improved pain and quality of life in patients with fibromyalgia.

Figures

Figure 1
Figure 1
Follow of participants in the study.
Figure 2
Figure 2
Comparison between study groups in levels of depression, anxiety, and pain. Values are presented as means with errors bars.

References

    1. Bennett R. Fibromyalgia: present to future. Current Rheumatology Reports. 2005;7(5):371–376.
    1. Cymet TC. A practical approach to fibromyalgia. Journal of the National Medical Association. 2003;95(4):278–285.
    1. Liptan GL. Fascia: a missing link in our understanding of the pathology of fibromyalgia. Journal of Bodywork and Movement Therapies. 2010;14(1):3–12.
    1. Häuser W, Eich W, Herrmann M, Nutzinger DO, Schiltenwolf M, Henningsen P. The Fibromyalgia syndrome: classification, diagnosis, and treatment. Deutsches Arzteblatt. 2009;106(23):383–391.
    1. Spaeth M, Briley M. Fibromyalgia: a complex syndrome requiring a multidisciplinary approach. Human Psychopharmacology. 2009;24:S3–S10.
    1. Jegede AB, Gilbert C, Tulkin SR. Muscle characteristics of persons with fibromyalgia syndrome. NeuroRehabilitation. 2008;23(3):217–230.
    1. Eisinger J, Plantamura A, Ayavou T. Glycolysis abnormalities in fibromyalgia. Journal of the American College of Nutrition. 1994;13(2):144–148.
    1. Hamilton NA, Affleck G, Tennen H, et al. Fibromyalgia: the role of sleep in affect and in negative event reactivity and recovery. Health Psychology. 2008;27(4):490–497.
    1. Desmeules JA, Cedraschi C, Rapiti E, et al. Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Current Rheumatology Reports. 2004;6, article 259
    1. Bradley LA. Pathophysiologic mechanisms of fibromyalgia and its related disorders. Journal of Clinical Psychiatry. 2008;69(2):6–13.
    1. Staud R, Vierck CJ, Cannon RL, Mauderli AP, Price DD. Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain. 2001;91(1-2):165–175.
    1. Nijs J, van Houdenhove B, Oostendorp RAB. Recognition of central sensitization in patients with musculoskeletal pain: application of pain neurophysiology in manual therapy practice. Manual Therapy. 2010;15(2):135–141.
    1. Zusman M. Forebrain-mediated sensitization of central pain pathways: ’non-specific’ pain and a new image for MT. Manual Therapy. 2002;7(2):80–88.
    1. Bennet R. Rheumatic Disease Clinics of North America. Philadelphia, Pa, USA: Saunders; 2002.
    1. Nijs J, van Houdenhove B. From acute musculoskeletal pain to chronic widespread pain and fibromyalgia: application of pain neurophysiology in manual therapy practice. Manual Therapy. 2009;14(1):3–12.
    1. Liptan GL. Fascia: a missing link in our understanding of the pathology of fibromyalgia. Journal of Bodywork and Movement Therapies. 2010;14(1):3–12.
    1. Ge HY, Nie H, Madeleine P, Danneskiold-Samsøe B, Graven-Nielsen T, Arendt-Nielsen L. Contribution of the local and referred pain from active myofascial trigger points in fibromyalgia syndrome. Pain. 2009;147(1–3):233–240.
    1. Wolfe F, Simons DG, Fricton J, et al. The fibromyalgia and myofascial pain syndromes: a preliminary study of tender points and trigger points in persons with fibromyalgia, myofascial pain syndrome and no disease. Journal of Rheumatology. 1992;19(6):944–951.
    1. Cakit BD, Taskin S, Nacir B, Unlu I, Genc H, Erdem HR. Comorbidity of fibromyalgia and cervical myofascial pain syndrome. Clinical Rheumatology. 2010;29(4):405–411.
    1. Ge HY, Wang Y, Danneskiold-Samsøe B, Graven-Nielsen T, Arendt-Nielsen L. The predetermined sites of examination for tender points in fibromyalgia syndrome are frequently associated with myofascial trigger points. Journal of Pain. 2010;11(7):644–651.
    1. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990. Criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis and Rheumatism. 1990;33(2):160–172.
    1. Karjalainen K, Malmivaara A, van Tulder M, et al. Multidisciplinary rehabilitation for fibromyalgia and musculoskeletal pain in working age adults. Cochrane Database of Systematic Reviews. 2000;(2) Article ID CD001984.
    1. Chesterton LS, Sim J, Wright CC, Foster NE. Interrater reliability of algometry in measuring pressure pain thresholds in healthy humans, using multiple raters. Clinical Journal of Pain. 2007;23(9):760–766.
    1. Carlsson AM. Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain. 1983;16(1):87–101.
    1. Spielberger CD. STAI. Cuestionario de Ansiedad Estado-Rasgo (State-Trait Anxiety Inventory Questionnaire) Madrid, Spain: TEA; 2007.
    1. Bonilla J, Bernal G, Santos A, Santos D. A revised Spanish version of the beck depression inventory: psychometric properties with a Puerto Rican sample of college students. Journal of Clinical Psychology. 2004;60(1):119–130.
    1. Lasa L, Ayuso-Mateos JL, Vázquez-Barquero JL, Díez-Manrique FJ, Dowrick CF. The use of the Beck Depression Inventory to screen for depression in the general population: a preliminary analysis. Journal of Affective Disorders. 2000;57(1–3):261–265.
    1. Jiménez-Genchi A, Monteverde-Maldonado E, Nenclares-Portocarrero A, Esquivel-Adame G, de la Vega-Pacheco A. Reliability and factorial analysis of the Spanish version of the Pittsburg Sleep Quality Index among psychiatric patients. Gaceta Médica de México. 2008;144(6):491–496.
    1. Dogan O, Ertekin S, Dogan S. Sleep quality in hospitalized patients. Journal of Clinical Nursing. 2005;14(1):107–113.
    1. Alonso J, Prieto L, Antó JM. The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): an instrument for measuring clinical results. Medicina Clinica. 1995;104(20):771–776.
    1. Pilat A. Terapias Miofasciales: Inducción Miofascial (Myofascial Therapies: Myofascial Induction) Madrid, Spain: McGraw-Hill; 2003.
    1. Schultz RL, Feitis R. The Endless Web, Fascial Anatomy and Physical Reality. Berkeley, Calif, USA: North Atlantis Books; 1996.
    1. Hooten WM, Townsend CO, Sletten CD, Bruce BK, Rome JD. Treatment outcomes after multidisciplinary pain rehabilitation with analgesic medication withdrawal for patients with fibromyalgia. Pain Medicine. 2007;8(1):8–16.
    1. Mason LW, Goolkasian P, McCain GA. Evaluation of a multimodal treatment program for fibromyalgia. Journal of Behavioral Medicine. 1998;21(2):163–178.
    1. Worrel LM, Krahn LE, Sletten CD, Pond GR. Treating fibromyalgia with a brief interdisciplinary program: initial outcomes and predictors of response. Mayo Clinic Proceedings. 2001;76(4):384–390.
    1. Häkkinen A, Häkkinen K, Hannonen P, Alen M. Strength training induced adaptations in neuromuscular function of premenopausal women with fibromyalgia: comparison with healthy women. Annals of the Rheumatic Diseases. 2001;60(1):21–26.
    1. Zijlstra TR, van de Laar MAFJ, Bernelot Moens HJ, Taal E, Zakraoui L, Rasker JJ. Spa treatment for primary fibromyalgia syndrome: a combination of thalassotherapy, exercise and patient education improves symptoms and quality of life. Rheumatology. 2005;44(4):539–546.
    1. Blackburn-Munro G. Hypotalmo-pituitary-adrenal axis dysfunction as a contributory factor to chronic pain and depression. Current Pain and Headache Reports. 2004;8(2):116–124.
    1. Angst F, Brioschi R, Main CJ, Lehmann S, Aeschlimann A. Interdisciplinary rehabilitation in fibromyalgia and chronic back pain: a prospective outcome study. Journal of Pain. 2006;7(11):807–815.
    1. Gustafsson M, Ekholm J, Broman L. Effects of a multiprofessional rehabilitation programme for patients with fibromyalgia syndrome. Journal of Rehabilitation Medicine. 2002;34(3):119–127.
    1. Hooten WM, Townsend CO, Sletten CD, Bruce BK, Rome JD. Treatment outcomes after multidisciplinary pain rehabilitation with analgesic medication withdrawal for patients with fibromyalgia. Pain Medicine. 2007;8(1):8–16.
    1. Gard G. Body awareness therapy for patients with fibromyalgia and chronic pain. Disability and Rehabilitation. 2005;27(12):725–728.
    1. Nicassio PM, Radojevic V, Weisman MH, et al. A comparison of behavioral and educational interventions for fibromyalgia. Journal of Rheumatology. 1997;24(10):2000–2007.
    1. Ramsay C, Moreland J, Ho M, Joyce S, Walker S, Pullar T. An observer-blinded comparison of supervised and unsupervised aerobic exercise regimens in fibromyalgia. Rheumatology. 2000;39(5):501–505.
    1. Strobel ES, Wild J, Müller W. Interdisciplinary group treatment for fibromyalgia. Zeitschrift fur Rheumatologie. 1998;57(2):89–94.
    1. Worrel LM, Krahn LE, Sletten CD, Pond GR. Treating fibromyalgia with a brief interdisciplinary program: initial outcomes and predictors of response. Mayo Clinic Proceedings. 2001;76(4):384–390.
    1. Segerstrom SC, Kemeny ME, Laudenslager ML. Individual difference factors in psychoneuroinmunology. Psychoneuroinmunology. 2001;2:87–109.
    1. Matarán-Peñarrocha GA, Castro-Sánchez AM, García GC, Moreno-Lorenzo C, Carreño TP, Zafra MD. Influence of craniosacral therapy on anxiety, depresión and quality of life in patients with fibromyalgia. Evidence-Based Complementary and Alternative Medicine. In press.
    1. Çitak-Karakaya I, Akbayrak T, Demirtürk F, Ekici G, Bakar Y. Short and long-term results of connective tissue manipulation and combined ultrasound therapy in patients with fibromyalgia. Journal of Manipulative and Physiological Therapeutics. 2006;29(7):524–528.
    1. Raj K, Chandra TS, Stanley MA. The enteric nervous system. New England Journal of Medicine. 1996;43:1106–1115.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir